ArticleOncoimmunology2022

An adjuvant-containing cDC1-targeted recombinant fusion vaccine conveys strong protection against murine melanoma growth and metastasis.

Mohammad Arabpour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.